Propofol versus midazolam for intubating preterm neonates: a randomized controlled trial

Area of Science:

• Neonatal Anesthesiology
• Pediatric Critical Care
• Pharmacology

Background:

• Establishing optimal premedication for neonatal tracheal intubation is crucial.
• Current ideal premedication regimens remain undefined.
• This study addresses the need for evidence-based choices in neonatal airway management.

Purpose of the Study:

• To compare intubation conditions using propofol versus midazolam as premedication in neonates.
• To evaluate the efficacy of two common hypnotic agents in neonatal tracheal intubation.
• To provide preliminary data on the safety and effectiveness of propofol in this population.

Main Methods:

• A double-blinded, randomized, controlled trial involving 20 preterm neonates (28-34 weeks gestation).
• Neonates received remifentanil with either propofol (n=10) or midazolam (n=10) prior to intubation.
• Intubation conditions were assessed using a standardized four-point scale.

Main Results:

• No statistically significant difference was observed in the number of intubation attempts between the propofol and midazolam groups.
• Overall intubation conditions showed no significant difference between the two premedication regimens (P = 1.00).
• The study did not identify a 50% difference in intubation conditions as the main outcome measure.

Conclusions:

• Both propofol and midazolam, when combined with remifentanil, yield comparable intubation quality in neonates.
• Propofol emerges as a potentially valid alternative hypnotic agent for premedication in neonatal endotracheal intubation.
• These findings may inform clinical practice regarding neonatal airway management.